Tacrolimus immediate release

DRUG2 trials

Sponsors

Astellas Pharma Global Development, Inc., Medical University of South Carolina

Conditions

Kidney TransplantationLiver Transplant; ComplicationsNeurotoxicity

Phase 4

To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients

CompletedNCT02723591

Astellas Pharma Global Development, Inc.Kidney Transplantation

Start: 2016-09-09End: 2019-06-14Updated: 2024-12-18

Envarsus Neurotoxicity Burden in Liver Transplant Patients

CompletedNCT03823768

Medical University of South CarolinaLiver Transplant; Complications, Neurotoxicity

Start: 2020-01-31End: 2024-01-30Updated: 2025-03-30

Related Papers

Results of a Randomized Controlled Trial Evaluating the Impact of Conversion to LCP Tacrolimus on Neurologic Toxicities in Liver Transplant Recipients.

2025-10-06